Files
Download Full Text (3.9 MB)
Description
• Benign prostatic hyperplasia (BPH) is the most common benign urological disease in men. 1
• Moderate-to-severe lower urinary tract symptoms (LUTS) from BPH affect 30% of men over 502 and medical treatment often fails for men with moderate-to-severe symptoms, leading them to seek surgical options. 3
• Transurethral resection of the prostate (TURP) remains the gold standard for prostates less than 80 mL; simple prostatectomy (SP) remains the standard for larger prostates.
• Aquablation (Aqua) is a novel BPH procedure that may be used for both small and large prostates from 50 to 150 mL. 4
• Although TURP has been compared with Aqua extensively, there is a gap in the literature regarding the direct comparison of Aqua to SP.
• SP, while a well-established operation, is an invasive procedure associated with a relatively high complication rate. 5,6
• Aqua potentially offers an endoscopic solution for men with large prostates.
Publication Date
5-2025
Keywords
Benign prostatic hyperplasia
Disciplines
Urology
Recommended Citation
Kuperus J, Jabeer M, Kennedy A, Horning P, Palmateer G, Zwaans BMM et al [Hafron J, Peters KM] Aquablation compared with simple prostatectomy for prostate volumes >80 grams. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2025 May; Rochester Hills, MI.
Comments
The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2025.